STATE PrEP/PEP PRIMER
PROVIDING PrEP/PEP IN THE PHARMACY SETTING UTAH EDITION
WHAT In January 2022, an amendment to the Utah State Pharmacy Practice Act, 58-17b-627(3)(a), which had been approved in the 2021 legislative session, became effective. The language of the bill can be found here: https://le.utah.gov/xcode/Title58/Chapter17B/5817b-P6.html?v=C58-17b-P6_1800010118000101.1 Pre-exposure prophylaxis (PrEP) is the use of specific combinations of antiretroviral agents to
reduce the risk of HIV infection in appropriately identified and evaluated HIV-negative people, and post-exposure prophylaxis (PEP) uses specific combinations of antiretroviral agents to prevent infection in appropriately identified and evaluated HIV-negative people who have had a single exposure that presents a substantial risk for HIV acquisition.2,3
Pharmacists are authorized to prescribe PrEP and PEP because it addresses a public health concern designated by the Department of Health and Human Services.
CALLING ALL PHARMACISTS! Launch Date: August
3, 2023
Expiration Date:
August 3, 2024
Target Audience
the activity addresses design of this pharmacists involved The educational and community needs of clinical for HIV. patients at risk in the care of
HOW TO OBTAIN CREDIT
questionnaire, complete the preactivity the score of 70% on Participants must receive a minimum evaluation online at complete and the program . posttest, and complete PrEPPharmMonograph
www.ExchangeCME.com/activity is 2 hours. Estimated time
to complete this
Arsalan “RC” PharmD, MBA
Shah,
of Pharmacy Senior Director Central City Concern Portland, Oregon
Group and by Global Education jointly provided This activity is Sciences, Inc. Integritas Communications. grant from Gilead an educational supported by This activity is
COMPREHENSIVE MONOGRAPH MEETS ALL OF YOUR BOARD OF PHARMACY REQUIREMENTS TO PRESCRIBE PEP/PrEP! www.ExchangeCME.com/PrEPPharmMonograph
This activity is jointly provided by Global Education Group and Integritas Communications. This activity is supported by an educational grant from Gilead Sciences, Inc.